Infographic: ocular cell and gene therapies – why the eye?

In this infographic, we look at key considerations to note when conducting ocular CGT studies. These considerations include common platforms for CGT bioanalytics, efficacy studies and safety–toxicity studies to conduct, as well as how to generate and provide preclinical information required for investigational new drug applications to enter clinical trials.

Ocular CGTs Absorption Systems

[Illustrated by Hannah Morton]

In association with: